FDA once again backs HPV vaccines as panel prepares to vote As an expert FDA panel prepared to meet this week to review new applications to market Cervarix to prevent cervical cancer in women and expand the use of Gardasil to prevent genital warts in males, both companies got … [Read more...] about FDA Staffers Stick With Their HPV Vaccine Position
The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them. As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for … [Read more...] about Rice Researchers Seek Better Vaccine Procedure to Target Flu Viruses
Fresh controversies are heating up over the marketing of products to prevent cervical cancer The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck … [Read more...] about Is Merck Overselling a Cancer Vaccine?
...Push Gardasil to achieve greater vaccination rates Less then a month after a JAMA article critized Merck for aggressively marking Gardasil, Merck is planning a big-time advertising push on Gardasil, hoping to revive flagging sales of the human papillomavirus vaccine. As … [Read more...] about Merck’s Back-to-School Special…
BioSante's vaccine adjuvant, BioVantTM, increases the protective effect of vaccines for multiple flu strains BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today's presentation of H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. … [Read more...] about BioSante Pharmaceuticals’ BioVantTM Adjuvanted Vaccine Reports 100% Protection From H1N1 Virus